Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 64.07 is 217% above its 5-year average of 20.24, near the high end of its 5-year range (8.00–64.07).
As of the fiscal period ended Tuesday, June 30, 2026. 61.32% above its 12-month average of 39.72.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 64.07.
CURRENT RATIO
64.07
CURRENT RATIO AVG TTM
39.72
CURRENT RATIO AVG 3Y
23.70
CURRENT RATIO AVG 5Y
20.24
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+61.32%
CURRENT VS 3Y AVG
+170.40%
CURRENT VS 5Y AVG
+216.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.38
median of 634 covered companies
CURRENT VS SECTOR MEDIAN
+1798.46%
vs the sector median at left
Enliven Therapeutics, Inc.
Market Cap
$2.97B
Current Ratio
64.07
TTM Avg
39.72
3Y Avg
23.70
5Y Avg
20.24
Market Cap
$3.07B
Current Ratio
12.12
TTM Avg
10.47
3Y Avg
8.70
5Y Avg
7.11
Market Cap
$3.08B
Current Ratio
2.92
TTM Avg
3.66
3Y Avg
6.49
5Y Avg
8.50
Market Cap
$2.84B
Current Ratio
12.02
TTM Avg
18.93
3Y Avg
12.46
5Y Avg
15.83
Market Cap
$2.69B
Current Ratio
1.57
TTM Avg
1.27
3Y Avg
1.13
5Y Avg
1.28
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | $2.97B | 64.07 | 39.72 | 23.70 | 20.24 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.04B | 8.37 | 8.81 | 8.76 | 9.71 |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.07B | 12.12 | 10.47 | 8.70 | 7.11 |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.08B | 2.92 | 3.66 | 6.49 | 8.50 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.84B | 12.02 | 18.93 | 12.46 | 15.83 |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 6.62 | 7.72 | 8.85 | 8.81 |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 4.22 | 3.80 | 3.72 | 4.10 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 1.57 | 1.27 | 1.13 | 1.28 |
| Neogen Corporation (NEOG)vs › | $2.68B | 3.82 | 3.57 | 3.75 | 5.68 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 1.16 | 1.32 | 1.06 | 0.97 |
Current Ratio
64.07
Quick Ratio
64.07
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 64.07 |
| 2026-03-31 | 40.32 |
| 2025-12-31 | 28.66 |
| 2025-09-30 | 32.95 |
| 2025-06-30 | 32.58 |
| 2025-03-31 | 21.06 |
| 2024-12-31 | 19.99 |
| 2024-09-30 | 17.44 |
| 2024-06-30 | 14.39 |
| 2024-03-31 | 13.47 |
| 2023-12-31 | 10.28 |
| 2023-09-30 | 22.24 |
| 2023-06-30 | 30.96 |
| 2023-03-31 | 27.23 |
| 2022-12-31 | 8.00 |
| 2022-09-30 | 10.59 |
| 2022-06-30 | 19.46 |
| 2022-03-31 | 10.87 |
| 2021-12-31 | 19.24 |
| 2021-09-30 | 14.75 |
| 2021-06-30 | 10.23 |
| 2021-03-31 | 14.60 |
| 2020-12-31 | 14.47 |
| 2020-09-30 | 18.78 |
| 2020-06-30 | 22.81 |
| 2020-03-31 | 22.19 |
| 2019-12-31 | 7.29 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
